Alternative first-line therapies in geriatric hypertension

Area of Science:

• Geriatrics
• Cardiology
• Pharmacology

Background:

• Hypertension affects 45-60% of elderly individuals, increasing morbidity and mortality.
• Secondary causes, like renovascular hypertension, are crucial to identify in older patients.
• Effective blood pressure reduction is vital for improving health outcomes in the elderly.

Purpose of the Study:

• To review current antihypertensive therapies for elderly patients.
• To highlight the efficacy and tolerability of specific drug classes.
• To examine the impact of treatment on quality of life and adverse effects.

Main Methods:

• Review of established antihypertensive treatments for elderly populations.
• Analysis of efficacy and tolerability data for diuretics, ACE inhibitors, and calcium-channel blockers.
• Consideration of drug interactions and quality-of-life implications.

Main Results:

• Low-dose thiazide diuretics are effective first-line agents.
• Angiotensin-converting enzyme (ACE) inhibitors and calcium-channel blockers are well-tolerated and effective.
• Combination therapy, particularly thiazide diuretics with ACE inhibitors, enhances efficacy and mitigates metabolic side effects.

Conclusions:

• Thiazide diuretics and ACE inhibitors are key components in managing elderly hypertension.
• Combination therapy offers improved efficacy and tolerability, positively impacting quality of life.
• Careful consideration of adverse effects and quality of life is essential in geriatric antihypertensive treatment.